Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP847916.RAXAmIEu3VEpfVkAHI4nPlaFvYuk-QRy28a078dH_9y98130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP847916.RAXAmIEu3VEpfVkAHI4nPlaFvYuk-QRy28a078dH_9y98130_assertion type Assertion NP847916.RAXAmIEu3VEpfVkAHI4nPlaFvYuk-QRy28a078dH_9y98130_head.
- NP847916.RAXAmIEu3VEpfVkAHI4nPlaFvYuk-QRy28a078dH_9y98130_assertion description "[We pharmacologically characterized pituitary adenylate cyclase-activating polypeptides (PACAPs), vasoactive intestinal peptide (VIP) and the VPAC(1), VPAC(2) and PAC(1) receptors in human meningeal (for their role in migraine) and coronary (for potential side effects) arteries.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP847916.RAXAmIEu3VEpfVkAHI4nPlaFvYuk-QRy28a078dH_9y98130_provenance.
- NP847916.RAXAmIEu3VEpfVkAHI4nPlaFvYuk-QRy28a078dH_9y98130_assertion evidence source_evidence_literature NP847916.RAXAmIEu3VEpfVkAHI4nPlaFvYuk-QRy28a078dH_9y98130_provenance.
- NP847916.RAXAmIEu3VEpfVkAHI4nPlaFvYuk-QRy28a078dH_9y98130_assertion SIO_000772 20974589 NP847916.RAXAmIEu3VEpfVkAHI4nPlaFvYuk-QRy28a078dH_9y98130_provenance.
- NP847916.RAXAmIEu3VEpfVkAHI4nPlaFvYuk-QRy28a078dH_9y98130_assertion wasDerivedFrom befree-2016 NP847916.RAXAmIEu3VEpfVkAHI4nPlaFvYuk-QRy28a078dH_9y98130_provenance.
- NP847916.RAXAmIEu3VEpfVkAHI4nPlaFvYuk-QRy28a078dH_9y98130_assertion wasGeneratedBy ECO_0000203 NP847916.RAXAmIEu3VEpfVkAHI4nPlaFvYuk-QRy28a078dH_9y98130_provenance.